Trial intelligence / Profile preview

Intralesional vitamin D3 versus cryotherapy for cutaneous warts

ACTRN12625001273471Phase 2Recruiting

Sponsor
Khyber Teaching Hospital
Start
Jan 2025
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 2, randomised, open-label trial of vitamin d in verruca, sponsored by Khyber Teaching Hospital. Started Jan 2025; status: recruiting.

02

Drugs

vitamin d
03

Conditions

verruca

Beyond the preview

Go deeper on ACTRN12625001273471.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ACTRN12625001273471.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call